OTCMKTS:MSSTF Mindset Pharma (MSSTF) Stock Price, News & Analysis $0.54 0.00 (0.00%) As of 10/27/2023 Add Compare Share Share Stock Analysis Stock Analysis About Mindset Pharma Stock (OTCMKTS:MSSTF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Mindset Pharma alerts:Sign Up Key Stats Today's Range$0.54▼$0.5450-Day Range$0.54▼$0.5452-Week Range$0.16▼$0.56VolumeN/AAverage Volume33,313 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.Read More… Remove Ads Receive MSSTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mindset Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address MSSTF Stock News HeadlinesMadrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 EarningsOctober 28, 2024 | seekingalpha.comCrispr Therapeutics: Poised For A Major TurnaroundOctober 28, 2024 | seekingalpha.comJeff Brown's Urgent March 17th AlertElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.March 13, 2025 | Brownstone Research (Ad)Why Indian students should choose Ireland as their study-abroad destination: Expert answers your questionsOctober 17, 2024 | msn.comNews snapshot: LithiumBank, Minto Metals, Versus Systems, Mindset Pharma, PyroGenesis, Soma Gold UPDATE...October 16, 2024 | proactiveinvestors.com.auThese three market leading stocks can plunge if Kamala Harris wins US electionsOctober 10, 2024 | msn.comTranscript: The Futurist: What’s Next with AI?October 3, 2024 | washingtonpost.comCelestica: Institutional Investors Are Buying, So Am ISeptember 27, 2024 | seekingalpha.comSee More Headlines MSSTF Stock Analysis - Frequently Asked Questions How have MSSTF shares performed this year? Mindset Pharma's stock was trading at $0.5381 at the beginning of 2025. Since then, MSSTF stock has increased by 0.0% and is now trading at $0.5381. View the best growth stocks for 2025 here. How do I buy shares of Mindset Pharma? Shares of MSSTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:MSSTF CIKN/A Webwww.mindsetpharma.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:MSSTF) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mindset Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mindset Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.